v2.4.0.6
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
3 Months Ended 173 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2013
OPERATING ACTIVITIES      
Net loss $ (744,890) $ (803,265) $ (46,605,617)
Depreciation     52,694
Gain on disposal of equipment     36,623
Stock-based compensation-product development costs 1,499   680,543
Stock-based compensation-interest expenses   231,948 13,330,984
Stock-based compensation-selling, general and administration 51,967   3,345,112
Stock-based compensation-professional fees 11,992   56,807
Other non-cash items included in net loss     294,020
Non-cash imputed interest expenses 301,247 482,689 25,073,284
Unpaid Interest expense on line of credit 95,884 82,142 718,169
Equity instruments issued to settle liabilities     1,871,718
Changes in operating assets and liabilities:      
(Increase) decrease in prepaid expenses 3,338 (13,900) (13,491)
Increase (decrease) in accounts payable and accrued liabilities 42,232 (41,475) 1,548,171
Increase in interest payable 126,518 126,391 4,402,434
Income tax receivable     8,727
Net cash used in operating activities (362,982) (376,362) (17,057,552)
INVESTING ACTIVITIES      
Purchase of equipment     (43,078)
Net cash used in investing activities     (43,078)
FINANCING ACTIVITIES      
Other financing activities     (115,472)
Expenditures to repurchase shares     (342,038)
Proceeds from issuance of shares     1,512,403
Increase in advances payable 5,000 5,000 3,157,071
Repayment of promissory notes payable     (970,879)
Proceeds from borrowings on line of credit 361,769 366,131 4,455,736
Proceeds from issuance of promissory notes     9,418,678
Net cash provided by financing activities 366,769 371,131 17,115,499
Change in cash 3,787 (5,231) 14,869
Cash, beginning of period 11,082 11,002  
Cash, end of period 14,869 5,771 14,869
Cash paid for interest   5,857  
Interest expense incurred in connection with options granted in exchange for increase in borrowing limit on existing line of credit financing   $ 1,493,702